SAGE Therapeutics (NASDAQ: SAGE) reported Q1 net loss of $122.1 million. Revenue for the quarter came in at $1.6 million versus the consensus estimate of $3.21 million.

For earnings history and earnings-related data on SAGE Therapeutics (SAGE) click here.